Vitamin C — Body Handbook

Supplements · §557

Vitamin C

Your body cannot build collagen — the stuff that holds skin, gums, blood vessels and bone together — without vitamin C. It also cannot make it itself, unlike almost every other mammal. So you eat it, every day, forever. The good news: about 200 mg a day saturates your tissues, and you can hit that with one large orange, half a red bell pepper and a cup of broccoli — or a 20-cent supplement. The bad news: most of what gets sold past that point is urinary waste, and one of the most-marketed claims — that it prevents colds — is mostly not true.

Do · Daily Evidence Moderate Chapter Supplements

Cheap, low effort, essential — eat one extra fruit-or-vegetable serving and you've done the job. The biggest practical wins land in two specific places: bleeding gums clear up in a few weeks if you've been running low, and iron from plant foods gets absorbed two to three times better when you eat it with vitamin C. Don't expect a cold-shield, an energy boost, or a longevity hack from a pill on top of an already-decent diet — those don't survive trial scrutiny.

Collagen is the rope that holds your soft body together — skin, gums, blood-vessel walls, tendons, the scaffolding inside your bones. The body builds it by stringing amino acids into a chain, then chemically twisting some of them sideways with an enzyme called prolyl hydroxylase. That sideways twist is what lets three chains lock into a stable triple helix. Without the twist, the helix falls apart at body temperature and the collagen comes out as wet noodle.

The enzyme that does the twisting runs on an iron atom in its core, and every time it finishes a twist that iron gets stuck in the wrong charge state. Vitamin C's job is to reset the iron so the enzyme can do the next twist. No vitamin C, no reset, no functional collagen. This is the same machinery in every collagen-producing tissue in the body, which is why a single missing nutrient produces a disease that hits gums, skin, joints and blood vessels at once — what 18th-century sailors called scurvy IOM 2000. It's also why a collagen supplement leans on your vitamin C status as much as its own dose: the peptides supply the building blocks, but without vitamin C on hand your body can't lock them into collagen that holds.

The second job is mopping up. Your cells produce reactive molecules — both as a normal byproduct of burning food, and during inflammation — that, left alone, damage DNA, fats and proteins. Vitamin C donates an electron to neutralize them in water-based parts of the body. It also rescues vitamin E mid-reaction at cell-membrane edges: vitamin E catches a damaging molecule, gets used up doing so, and vitamin C hands it the electron it needs to go again. The two nutrients work as a tag team and neither does the same job alone Carr & Frei 1999.

The third job is in your gut. Iron from plants — beans, spinach, fortified cereals — comes locked in a form your intestine cannot absorb, much of it bound up by the phytic acid in the same plants. Vitamin C in the same meal pries it loose into the absorbable form. Take iron with orange juice and you absorb two to three times as much as iron with water Hallberg 1987.

What's settled, and what isn't

The pharmacokinetics are nailed down. A team at the NIH put healthy young men in a hospital for months on a near-zero vitamin C diet, then titrated dose up from 30 mg to 2,500 mg a day and tracked what showed up in blood, white blood cells, and urine. The picture is a flat-topped curve: blood levels rise steeply between 30 and 100 mg, plateau around 200 mg, and don't move much above that. White blood cells fully saturate at 100 mg. Above about 500 mg per dose, less and less of what you swallow gets absorbed, and what does gets peed out within hours.

The collagen story holds up at every level: animals engineered to lack vitamin C develop scurvy; sailors did historically; the gums of vitamin-C-deficient adults bleed and the gums of repleted ones don't Tada & Miura 2024. A 2024 review pooled 18,000 people across periodontal-health studies and found a consistent association between higher vitamin C intake and lower gum-disease risk.

The cold story is more interesting because the answer is partly counterintuitive. The Cochrane review pooled 29 trials with 11,000 participants and asked two questions. Does daily vitamin C prevent colds? Almost certainly no — not for normal people. Does it shorten them? Yes, modestly: about 8% shorter in adults, 14% shorter in kids, taking at least 200 mg a day. Then there's a striking exception.

The longevity story is where the evidence splits clean down the middle. People with the highest blood vitamin C die at about half the rate of people with the lowest, in cohort after cohort, across hundreds of thousands of participants Khaw et al. 2001 Aune et al. 2018. But when researchers gave people vitamin C pills in randomized trials and watched for years, no mortality benefit appeared. The likeliest reading: high blood vitamin C tags a fruit-and-vegetable-eating life, not a molecule you can swap in via tablet. The molecule is necessary; the pill, on top of a normal diet, is not what's doing the work.

What running low actually looks like

Frank scurvy is rare now, but a low-grade version isn't. About one in fifteen US adults has blood vitamin C in the deficient range — concentrated in smokers, the food-insecure, the elderly living alone, and people on diets where fruit and vegetables show up once a week if at all. The symptoms creep in slowly and get attributed to other things.

The earliest sign most people notice is gums that bleed every time they brush. Bruises that linger longer than they used to. A cut that takes a week and a half to close instead of three days. You catch yourself feeling worn out by the early afternoon despite sleeping fine. None of these are the dramatic scurvy of sailor diaries — the loose teeth, the corkscrew hairs on the legs, the old wounds reopening because the collagen holding the scar together literally falls apart. That picture takes months of near-zero intake and you'll see your doctor before you get there. But the half-deficient version is silent and common and gets shrugged off as getting older.

The longer-term picture lives in the cohort studies. People sitting in the bottom fifth of blood vitamin C have roughly double the all-cause death rate of people in the top fifth, tracked over years Khaw et al. 2001. Most of that gap is whatever else those people eat — the high-vitamin-C person is also eating fiber, folate, polyphenols, and a hundred other things. But the molecule sits in the middle of so much basic machinery that being chronically half-supplied is genuinely unlikely to be neutral.

How to actually get enough

Aim for about 200 mg a day. That is the saturation point in the blood-level studies — past that you're just making expensive urine Levine 1996. The US official recommendation is lower (75–90 mg, set as a deficiency-prevention floor), but the dose that actually fills your tissues is 200 mg and that's what reasonable researchers have been arguing for since the 1990s Carr & Frei 1999.

You can hit it easily from food. None of these are unusual:

If supplementing is easier than juggling produce, plain ascorbic acid tablets at 250–500 mg once a day cost about ten dollars a year. The supplement and the orange both put the same molecule in your bloodstream. Don't pay extra for "natural," "liposomal," or "whole-food" forms — the head-to-head pharmacokinetic data don't back the marketing.

Two timing rules earn their keep:

Cooking destroys some of it — boiling vegetables and tossing the water loses 25 to 50%. Steaming, sauteeing, or eating raw keeps most of it. Fresh fruit sitting in the fridge loses about a quarter per week, so a bag of oranges bought two weeks ago is not the same as a bag bought today.

When more is actually worse

For everyone else, the upper safe limit is 2 grams a day set by the Institute of Medicine, mostly to avoid diarrhea and abdominal cramping from the unabsorbed surplus pulling water into the gut IOM 2000. There is no good reason to be anywhere near that line.

What the marketing gets wrong

"It prevents colds." The Cochrane review is unambiguous: continuous daily vitamin C does not change how often the average person gets a cold Hemilä & Chalker 2013. It shortens them slightly (by about a tenth) and there is a real benefit if you're about to run a marathon or ski across a mountain — but the bottle promising you skip cold season is selling something the trials don't support.

"More is better." The dose-response curve has a hard ceiling at about 200 mg a day for blood levels and 400 mg a day for tissue saturation. Above that, your gut absorbs less and your kidneys flush the surplus within hours Levine 1996. The mega-dose pills aren't doing anything the small pills couldn't.

"Megadose vitamin C treats cancer." This was Linus Pauling's argument in the 1970s. The Mayo Clinic ran three randomized placebo-controlled trials of 10 grams a day oral vitamin C in advanced cancer; none showed any survival or symptom benefit over placebo Moertel et al. 1985. Intravenous high-dose vitamin C is a separate thing — it produces blood concentrations oral dosing can't reach Padayatty et al. 2004 — and is still under research, but it's a clinic procedure, not something you do with pills.

"Liposomal vitamin C is way more bioavailable." The marketing claims of 5x or 10x absorption aren't supported when you actually compare them head-to-head against plain ascorbic acid at matched doses. Some studies show a small advantage; most show none. The molecule that ends up in your bloodstream is the same molecule.

"You can't get enough from food." One large orange covers half a day. Anyone eating two to three normal servings of fruit or vegetables daily is already past the saturation dose.

What changes if you fix this

How much you notice depends entirely on where you're starting. If you've been running low — half a piece of fruit a day, gums that bleed every brushing — the change is real and fast. If you're already eating two or three servings of fruit and vegetables daily, adding a pill on top will be invisible. The bottle does not lift you above the saturation point.

For the running-low reader, two to four weeks in: gums stop streaking the toothbrush red. Cuts and scrapes scab over and close on a normal schedule again. Bruises from bumping into furniture fade in days instead of weeks. The afternoon fatigue that you'd written off as work stress lifts somewhat — not dramatically, but enough to notice when it's gone.

One to three months in: if you've been pairing your vitamin C with iron-rich meals, blood iron starts climbing — particularly if you're a woman of reproductive age, vegetarian, or both. The lift in iron does what low iron was hiding: less breathlessness on stairs, the cold hands that have been your whole life turn out to be optional, the energy floor under the day settles up an inch Hallberg 1987.

Over years and decades, the picture is harder to feel. The cohort data say people maintaining the top fifth of blood vitamin C levels have roughly half the cardiovascular and all-cause mortality of those in the bottom fifth Khaw et al. 2001 Aune et al. 2018. Most of that gap is the broader pattern of eating that gets you there — fruit, vegetables, plant variety — rather than the single nutrient. But you don't get the top quintile of blood vitamin C without that eating pattern, and you don't lose much by aiming for it.

The people who get the most out of this

Most of the leverage in this entry sits with specific groups, not the average reader.

If you smoke or vape, you burn through vitamin C at roughly twice the normal rate, and your blood levels run 30–50% lower than a non-smoker eating the same amount. The IOM adjusts the recommendation up by 35 mg/day for smokers, but the underlying turnover studies suggest that's an undercount and you probably need closer to 200 mg/day total to match a non-smoker's status Schectman et al. 1989. Quitting is the real fix; while you haven't, this is one of the cheaper ways to limit the damage.

If you're vegetarian or vegan, your fruit-and-vegetable intake almost certainly has you covered for vitamin C itself. What matters is using it: take it in the same meal as plant iron sources — beans, lentils, leafy greens, fortified cereals — to multiply absorption. Drinking orange juice with a lentil soup is a real strategy, not just diet culture.

If you have heavy periods or are pregnant, your iron demand is high and your absorption matters. Pairing vitamin C with iron-rich foods or iron supplements increases the amount your gut actually picks up by two- to threefold in single-meal tests Hallberg 1987.

If you're over 65 and living alone or in a care facility, you're in the highest-risk group for low intake. Fresh fruit drops out of the routine, and the slow-burn deficiency (bruising, slow wounds, fatigue) gets blamed on age rather than nutrition. A daily supplement is one of the cheapest interventions on the menu.

If you train hard or compete in endurance sports, this is the one case where supplementation actually does cut cold rates — by roughly half, in trials of marathoners, skiers, and soldiers under heavy physical load Hemilä & Chalker 2013. Worth taking through a heavy training block.

Adjacent things worth knowing about

This entry covered vitamin C as a daily nutrient swallowed from food or pills. A few neighbouring topics worth chasing separately when you have time:

Topical vitamin C serums for skin — a different intervention with its own randomized-trial base (5–10% L-ascorbic acid applied to the face) showing real wrinkle and pigmentation effects over months. Looks the same on the label, works through skin not gut, separate question.
Iron, ferritin, and how to read your blood-iron numbers — pair-reading with this entry if you've ever been told your iron is low.
Intravenous vitamin C in cancer and critical care — clinic-administered, achieves blood levels oral dosing cannot, active research area, not a consumer decision.
Fruit and vegetable intake generally — the diet pattern that puts your blood vitamin C in the top fifth carries a hundred other nutrients along with it. The pill is a piece of that puzzle, not a substitute.

Related in the handbook

Worsens / aggravates

— Above a gram a day, supplemental vitamin C raises the oxalate your body makes and can feed kidney stones.

Helps

— Vitamin C with a meal pulls two to three times more iron out of plant foods; pair them on purpose.

— Your body can't build collagen without vitamin C, so it's the cofactor behind any collagen you take or make.
— Eating vitamin C with a plant-based meal counters phytic acid, pulling more of the bound iron into your blood.
— Cooking veg can wipe out their vitamin C. Eat some raw, or cook only briefly, to keep what's there.
— Eating vitamin C builds collagen from the inside; the topical version is a genuine skincare active that does a related job on your face.
— If you've been running low, bleeding gums clear up within weeks of getting enough vitamin C.

1. Substance and claimed effects

Vitamin C (L-ascorbic acid) is a water-soluble essential micronutrient. Humans, unlike most mammals, lack functional L-gulonolactone oxidase and cannot synthesize it; intake from diet or supplements is obligatory IOM 2000. The substance is biologically active as both a redox cofactor (donating electrons to keep iron- and copper-dependent enzymes in their reduced state) and a direct aqueous-phase antioxidant. The catalogue's scope on this entry is daily oral intake (food + supplements) and the consequences that flow from it: collagen and connective-tissue biology (skin, gums, vasculature, bone), non-heme iron absorption, regeneration of other antioxidants (chiefly α-tocopherol), immune function (epithelial barrier, neutrophil function), cardiovascular markers, and overall mortality signal. Topical (cosmetic) ascorbic acid serums and intravenous high-dose oncology protocols are flagged in §3b but not the primary subject — they are separate substances pharmacokinetically Padayatty et al. 2004.

2. Evidence by addressing question

mechanism

Two mechanistic roles carry the substance:

Redox cofactor for Fe²⁺/α-ketoglutarate-dependent dioxygenases. Prolyl 4-hydroxylase and lysyl hydroxylase hydroxylate proline and lysine residues on nascent procollagen chains; the hydroxyl groups are required for the triple helix to be thermally stable at 37 °C. The active-site iron oxidizes during each catalytic cycle; ascorbate reduces it back to Fe²⁺. Without ascorbate, hydroxylation fails, procollagen denatures intracellularly or is secreted as weak unstable collagen — the molecular lesion behind scurvy's bleeding gums, hemorrhage, impaired wound healing, and bone fragility. Same enzyme family hydroxylates HIF-1α (oxygen sensing) and carnitine precursors (fatty-acid β-oxidation) IOM 2000.
Terminal aqueous-phase antioxidant. Ascorbate donates a single electron to scavenge ROS/RNS in plasma and cytosol, becoming the relatively stable ascorbyl radical. Critically, it also regenerates the α-tocopheroxyl radical at the lipid-water interface, returning vitamin E to its active form before it can decompose to inert tocopherolquinone. Glutathione and NADPH-dependent reductases then recycle dehydroascorbate back to ascorbate. The C/E synergy is the basis for the "antioxidant network" framing of these nutrients Carr & Frei 1999.

A third mechanism, narrowly important for nutrition: ascorbate reduces dietary Fe³⁺ (ferric, the form in plant foods and supplements) to Fe²⁺ (ferrous, the form that crosses the enterocyte apical membrane via DMT1) and forms a soluble ferric-ascorbate chelate that resists inhibition by phytate, polyphenols, and calcium — the basis of vitamin C's enhancement of non-heme iron absorption Hallberg 1987.

evidence

Pharmacokinetics and the dose ceiling. Levine and colleagues at NIH ran the definitive depletion–repletion studies in healthy young men (1996) and women (2001), hospitalizing volunteers for months on <5 mg/d intake and titrating ascorbate dose. Steady-state plasma concentration follows sigmoid kinetics: the steep portion runs from 30 to 100 mg/d, plasma plateaus around 70 μmol/L by 200 mg/d, and tissue cells (neutrophils, lymphocytes) saturate at 100–400 mg/d. Bioavailability is essentially 100% up to a single 200 mg dose, drops to ~73% at 500 mg, and ~33% at 1250 mg; absorbed surplus above ~200 mg is excreted unchanged in urine. Oxalate and urate excretion rise at 1 g/d. These data drove the 2000 IOM RDA upward to 90 mg/d (men) and 75 mg/d (women), with a tolerable upper intake level (UL) of 2 g/d Levine et al. 1996 IOM 2000.

Common cold. The Cochrane review (Hemilä & Chalker, 29 trials, 11,306 participants) is the cleanest answer: continuous prophylactic vitamin C (≥200 mg/d) does not reduce the incidence of colds in the general population (pooled RR ~0.97). It does shorten duration modestly — about 8% in adults and 14% in children — and reduces severity by a similar margin. The one striking subgroup: five trials in people undergoing brief intense physical stress (marathon runners, skiers, soldiers in subarctic exercises) showed risk of cold roughly halved (RR 0.48, 95% CI 0.35–0.64) at doses 0.25–1 g/d. Therapeutic vitamin C started at symptom onset has not shown consistent benefit at trial-tested doses, though Hemilä notes the dose-response question is not yet settled Hemilä & Chalker 2013.

Cardiovascular and total mortality. The EPIC-Norfolk prospective cohort (Khaw et al., 19,496 adults aged 45–79, 4-year follow-up) found a graded inverse relationship between plasma ascorbate quintile and all-cause, cardiovascular, and ischemic heart disease mortality: each 20 μmol/L rise in plasma vitamin C corresponded to ~20% lower all-cause mortality, with the highest vs. lowest quintile showing roughly half the death rate. The Aune meta-analysis (15 prospective cohorts, >500,000 participants) confirmed dose-response inverse associations of dietary and circulating vitamin C with CVD mortality, with pooled RR ~0.65 for highest vs. lowest Khaw et al. 2001 Aune et al. 2018. The catch: large RCTs of vitamin C supplementation (Physicians' Health Study II, Women's Antioxidant Cardiovascular Study) have not reproduced the protection, so the observational signal probably tags fruit-and-vegetable-eating patterns and residual confounding rather than a discrete causal effect of the molecule. EPIC-Norfolk authors themselves note this gap.

Iron absorption. Hallberg's radioisotope studies in the 1970s–80s established the enhancement: 25–75 mg of ascorbic acid eaten alongside a non-heme iron meal increases iron absorption 2- to 4-fold in single-meal studies, with the effect rising with dose up to ~1 g. The long-term picture is more modest: in iron-replete people, the body downregulates absorption via hepcidin, and observational studies of habitual vitamin C intake do not show large effects on serum ferritin in already-replete adults. The intervention earns its keep specifically for iron-deficient and plant-based eaters Hallberg 1987.

Skin and connective tissue. Oral evidence is largely deficiency-driven: in scurvy, perifollicular hemorrhages, corkscrew hairs, and impaired wound healing resolve within weeks of repletion. For non-deficient adults, oral supplementation effects on skin appearance are small and inconsistent. Topical ascorbic acid at 5–10% has stronger RCT evidence: Humbert et al. ran a 6-month double-blind RCT of 5% L-ascorbic acid cream vs. excipient on photoaged forearm/neck skin in healthy women, and saw measurably reduced deep wrinkle depth and improved skin texture on silicone rubber replicas, with biopsy showing increased type I/III collagen mRNA Humbert et al. 2003. This is a separate substance from dietary vitamin C and only flagged here for completeness.

Periodontal/gum health. A 2024 systematic review and meta-analysis (Tada & Miura, 17,853 participants pooled across observational studies) found higher vitamin C intake associated with lower periodontal disease risk. Subgroup signal: gingival bleeding improves with repletion in low-intake individuals; established periodontitis with alveolar bone loss does not reverse with vitamin C alone Tada & Miura 2024.

Immune function (beyond colds). Carr & Maggini reviewed mechanism: ascorbate accumulates in neutrophils at ~50× plasma concentration, enhances chemotaxis, supports the oxidative burst, then is consumed during phagocyte recycling. Plasma vitamin C drops sharply during acute infection, sepsis, and surgery, suggesting demand outpaces normal intake under those conditions. Repletion data in sepsis and pneumonia are still mixed; the CITRIS-ALI trial showed a mortality signal in sepsis-induced ARDS but with caveats Carr & Maggini 2017.

protocol

RDA: 90 mg/d adult men, 75 mg/d adult women, plus 35 mg/d for smokers. UL 2 g/d IOM 2000. The pharmacokinetic envelope (Levine 1996) suggests targeting 200 mg/d for full tissue saturation in non-smokers — achievable from one large orange + half a red bell pepper + one cup of broccoli, or any equivalent fruit/vegetable combination. Carr & Frei argued for 200 mg/d as the rational target on antioxidant and pharmacokinetic grounds rather than the IOM's 75–90 mg deficiency-prevention floor Carr & Frei 1999. Supplement form: ascorbic acid (cheapest, identical absorption to "natural" sources), 250–500 mg/d split if higher doses pursued; doses >1 g are urinarily wasted in healthy adults Levine et al. 1996. Buffered (sodium/calcium ascorbate) forms reduce GI irritation but cost more; liposomal forms have marketing claims of higher bioavailability that are not well-supported in head-to-head pharmacokinetic data.

contraindications

Hereditary hemochromatosis and other iron-overload states (thalassemia major, transfusion-dependent anemias): high-dose ascorbate can mobilize stored iron into plasma, with case reports of acute cardiac toxicity in thalassemia. Supplements should be avoided; whole-food vitamin C from fruit is generally acceptable but should not be paired with iron-rich meals IOM 2000.
History of calcium oxalate kidney stones. Ascorbate is partially metabolized to oxalate; the Thomas et al. (2013) Swedish men's cohort (n=23,355, 11 years) found supplement users had roughly double the incident stone risk (HR ~1.92) at typical multivitamin doses. Curhan's NHS women's cohort did not see the same signal in females. Recommendation: stone-formers limit supplemental vitamin C to ≤500 mg/d Thomas et al. 2013.
G6PD deficiency: very high-dose IV vitamin C can trigger hemolysis; oral doses within UL are not implicated.
Chronic kidney disease: reduced oxalate clearance compounds the stone risk; high-dose supplements (>500 mg/d) should be avoided.

misconceptions

"Vitamin C prevents colds." The Cochrane data are clear: continuous high-dose intake does not reduce cold incidence in the general population. The effect is on duration (~8–14%) and on a high-physical-stress subgroup Hemilä & Chalker 2013.
"More is better." Above ~400 mg/d, plasma plateaus and absorption fraction drops sharply; above 1 g/d, the excess is excreted in urine and contributes to oxalate load Levine et al. 1996.
"Liposomal/whole-food forms are dramatically more bioavailable." Head-to-head pharmacokinetic comparisons show identical or only marginally higher AUC for liposomal preparations at typical doses; the molecule is the same molecule.
"Megadose vitamin C cures cancer." Three randomized placebo-controlled Mayo Clinic trials (Moertel et al. 1985 the definitive one) found no benefit of oral 10 g/d in advanced cancer. The IV-vitamin-C cancer hypothesis is a separate, pharmacokinetically distinct intervention still under research and not relevant to dietary intake decisions Moertel et al. 1985 Padayatty et al. 2004.
"Smoker's 35 mg add-on is enough." Schectman's NHANES II analysis suggested smokers actually need closer to 200 mg/d (an extra ~130 mg over the non-smoker RDA) to match non-smoker plasma levels, due to ~2× turnover from oxidative load — a gap the IOM acknowledged but did not act on Schectman et al. 1989.

audience

Population-specific notes:

Smokers and heavy second-hand smoke exposure: +35 mg/d per IOM, likely under-stated; reasonable to target ≥200 mg/d Schectman et al. 1989.
Vegetarians/vegans: typically have higher dietary vitamin C than omnivores (fruit/vegetable-heavy diets), so deficiency is rare, but they have the biggest practical reason to keep intake high — non-heme iron absorption depends on it.
Iron-deficient women of reproductive age: 100+ mg vitamin C taken with iron-rich meals or iron supplements meaningfully boosts absorption.
Older adults: intake often falls below RDA due to reduced fruit/vegetable intake; supplementation more often warranted.
Pregnancy/lactation: RDA raises modestly (85 mg pregnancy, 120 mg lactation per IOM); no safety concerns at dietary or RDA-level intakes.
Critically ill/sepsis patients: plasma vitamin C falls profoundly; active research area, not yet a guideline-level recommendation.

alternatives

For the antioxidant role, dietary polyphenols (berries, tea, cocoa) and other antioxidant vitamins (E, carotenoids, glutathione precursors) partially overlap but cannot substitute — none reduce the catalytic-cycle iron in prolyl hydroxylase. For iron absorption enhancement, organic acids (citric, lactic) and heme iron from animal sources are alternative routes. There is no functional alternative to ascorbate for collagen hydroxylation; the substance is irreplaceable. Whole foods (orange, kiwi, red bell pepper, broccoli, strawberry, blackcurrant, guava) vs. supplements: equivalent on a per-mg basis, but whole foods deliver matrix nutrients (folate, fiber, polyphenols) and a more favorable epidemiological profile.

practicalities

Cost: a year's supply of generic 500 mg ascorbic acid tablets runs ~$10–15. Food sources are cheap and ubiquitous in temperate diets. Cooking destroys 25–50% via heat and oxidation, more if water is discarded — relevant for boiled vegetables, less for raw fruit or briefly steamed/sauteed vegetables. Storage: tablets stable for years; fresh fruit/vegetable loses ~25% per week of refrigerated storage. Plasma half-life is short (~2 hours at low body store, ~8–40 days at saturation); splitting higher doses into 2–3 portions across the day raises steady-state plasma more than a single bolus.

stakes

Frank scurvy is rare in industrialized populations but not extinct — case series document it in elderly isolated adults, alcoholics, people with eating disorders, and infants on inappropriate formula. Modern deficiency more commonly looks subclinical: fatigue, easy bruising, slow wound healing, gum bleeding — symptoms that get attributed to other causes. Plasma vitamin C in the lowest quintile (<17 μmol/L) maps to roughly doubled all-cause mortality risk in EPIC-Norfolk; whether the molecule itself or what it indexes drives that signal is contested, but the consistent association is hard to dismiss across multiple cohorts Khaw et al. 2001 Aune et al. 2018. NHANES estimates ~6–7% of US adults have plasma levels in the deficient range, with higher prevalence in low-income, smokers, and food-insecure populations.

payoff

For someone moving from baseline-low intake (one fruit/vegetable serving daily) to consistent saturation (200+ mg/d): gum bleeding on flossing tends to resolve within 2–4 weeks; bruising and slow wound healing improve over weeks; iron-deficient women on plant-based diets see meaningful ferritin/hemoglobin response when vitamin C is paired with iron-rich meals over months. For a baseline-replete reader (already eating fruit/vegetable-rich diet), supplementation provides little perceptible benefit — the marginal utility curve flattens hard above the RDA. The CVD/longevity association from observational data is genuine but small in absolute terms and probably not driven by the molecule in isolation.

history

Scurvy killed an estimated 2 million sailors between 1500 and 1800. James Lind's 1747 trial on HMS Salisbury — 12 scorbutic sailors randomized across six treatments, with citrus producing dramatic recovery — is widely cited as the first controlled clinical trial. Routine lime/lemon ration in the Royal Navy from 1795 functionally eradicated scurvy at sea. Albert Szent-Györgyi isolated "hexuronic acid" (later renamed ascorbic acid) from adrenal cortex and paprika in 1928–32, winning the 1937 Nobel in Physiology or Medicine. Linus Pauling's 1970 Vitamin C and the Common Cold ignited the megadose movement; the Mayo Clinic trials of the late 1970s and 1985 settled the oncology claim against Pauling and shaped the modern regulatory caution about supraphysiologic dosing Moertel et al. 1985.

out-of-scope

Adjacent topics not covered in this entry: topical vitamin C serums for skin (a separate cosmeceutical with its own RCT base — Humbert 2003 and others); intravenous high-dose vitamin C in oncology (pharmacokinetically distinct from oral; active clinical-research area); CITRIS-ALI and other sepsis/critical-care vitamin C protocols (clinician-administered, not consumer-actionable); vitamin C as an additive to iron-deficiency supplementation protocols (overlaps with iron entry); and dietary patterns more broadly (fruit-and-vegetable intake is a multi-nutrient signal of which vitamin C is only one component).

3. Credibility range

Optimist case

Vitamin C is one of the few nutrients where the mechanistic chain — cofactor for collagen hydroxylation, iron reduction, vitamin E recycling, neutrophil function — is fully worked out at the molecular level. Frank deficiency produces a textbook, reproducible disease (scurvy) that resolves on repletion. The Cochrane data on the high-physical-stress subgroup (halved cold incidence) is large and consistent across five trials. EPIC-Norfolk and the Aune meta-analysis show a robust inverse association between plasma vitamin C and cardiovascular/total mortality across 500,000+ participants. Iron-absorption enhancement is dose-responsive, mechanistically clean, and clinically useful in iron deficiency. The substance is cheap, abundantly available in normal diets, and has an unusually safe profile at doses up to 1 g/d in healthy adults. The optimist concludes: this is an essential nutrient whose status is worth measuring and, if low, fixing — across populations.

Skeptic case

The most-marketed claims do not survive RCT scrutiny. Continuous supplementation does not prevent colds in the general population. Three placebo-controlled trials refuted the megadose cancer hypothesis. Large CVD prevention RCTs (PHS II, WACS) found no benefit of vitamin C supplementation despite the observational signal — strong evidence that the EPIC-Norfolk/Aune association is confounded by fruit/vegetable patterns and overall health behaviors. Above the ~200 mg saturation point, additional intake is urinary waste at best and a kidney-stone risk for men at worst. Most of the population in industrialized countries already gets enough from food; supplements are mostly addressing a problem that does not exist for the typical reader. The skeptic concludes: get adequate vitamin C from food and stop there; the supplement industry vastly overstates the benefit of pushing intake past RDA.

Author's call

Both cases are partly right and the entry should resolve them honestly. The molecular mechanism is real and irreplaceable; the deficiency disease is real; the iron-absorption and gum-bleeding effects are real and clinically useful for the populations that need them. The cold-prevention and longevity claims at the consumer-marketing level overshoot what the trials support. The right reader frame is: get to ~200 mg/d from food if you can, supplement modestly if you can't, don't megadose. Score evidence at 4 (decades of trials, IOM guideline, Cochrane review, but population RCTs disappointing on the headline-grabbing claims). Score controversy at 2 (the mechanism and RDA are settled; the supplement-dosing fights are real but at the margins, not at the foundations).

4. Stakeholder and incentive map

Supplement industry: vitamin C is one of the highest-volume single-ingredient supplements globally; immune-claim marketing during cold/flu season and around every infectious-disease event (COVID-19 included) drives sales. Strong commercial incentive to inflate the cold-prevention message.
Mainstream nutrition guidelines (IOM, EFSA, WHO): aligned at the RDA level (~75–110 mg/d depending on body), conservative on supplementation past UL. Professional incentive to set safe defaults, not to optimize for marginal benefits.
Orthomolecular medicine / Pauling legacy: still vocal community advocating multi-gram daily doses; less mainstream-credible after the Mayo trials but persistent online.
Functional medicine and IV-clinic operators: commercial incentive to promote high-dose IV vitamin C for chronic fatigue, cancer adjunctive use, and wellness; evidence base for most indications is thin.
Dental and dermatology communities: mostly aligned with the periodontal-bleeding and topical-skin evidence; little dispute.
Kidney-stone urology: has flagged the male kidney-stone signal repeatedly; consistent professional pushback against supplemental megadosing for stone-formers.

5. Population variability

Smokers have ~30–50% lower plasma vitamin C than non-smokers at the same intake; turnover roughly doubles. The IOM +35 mg/d is acknowledged in the literature to be conservative — Schectman's analysis suggests +130 mg/d to fully close the gap Schectman et al. 1989.
Sex: women have ~10–20% higher plasma vitamin C than men at equivalent intake (body composition, estrogen interactions); RDA is correspondingly lower. The kidney-stone supplement signal is observed in men, not women.
Age: intake reliably falls in older adults; absorption efficiency is largely preserved but dietary fruit/vegetable intake drops. Highest deficiency prevalence in 65+ free-living adults and institutionalized elderly.
Genetic variation: SLC23A1/SLC23A2 polymorphisms (the SVCT1/SVCT2 vitamin C transporters) affect steady-state plasma levels modestly; haptoglobin Hp2-2 phenotype associated with lower plasma vitamin C and higher CVD risk.
Diet pattern: plant-forward and Mediterranean diets routinely deliver 150–300 mg/d from food alone; ultra-processed-heavy diets often fall below 60 mg/d.
Acute stress (sepsis, surgery, severe burns, ICU): plasma drops profoundly, sometimes to scorbutic levels within days. Active research area; oral repletion may be inadequate, and IV is increasingly used in critical care.

6. Knowledge gaps

Why the observational vitamin C / CVD-mortality signal does not replicate in RCT supplementation — confounding by overall diet pattern is the leading explanation, but residual mechanism (e.g., vascular endothelial function in chronic low-grade deficiency) is plausible.
Whether the EPIC-Norfolk effect at the low-plasma end is reversible by supplementation alone, or only by the diet pattern that produces high plasma levels.
Optimal dose and form in sepsis/critical illness — the CITRIS-ALI mortality signal needs replication and a dose-response RCT.
Whether the smoker turnover rate justifies a separate, higher RDA, and whether vapers fall into the same metabolic category.
Long-term consequences of habitual high-dose supplementation (1–2 g/d) on kidney function, beyond the established stone signal in male cohorts.
Bioavailability of liposomal and other newer formulations vs. plain ascorbic acid at matched doses, in head-to-head pharmacokinetic studies — the marketed claims outstrip the data.

Scope vs. brief. The brief named collagen synthesis, iron absorption, antioxidant regeneration, immune function, skin, gum health, and cardiovascular markers. All seven are covered in the article — collagen and antioxidant regeneration in mechanism; iron absorption in mechanism, protocol, payoff, and the audience block for vegetarians; immune function via the cold/Cochrane evidence in evidence and the endurance-athlete audience block; skin in the deficiency picture under stakes and payoff; gum health in mechanism, evidence, and payoff; cardiovascular markers via EPIC-Norfolk and Aune in evidence, stakes, payoff. No silent narrowing.

Excluded by design.

Topical vitamin C serums. Flagged in research §3b and in the out-of-scope section, but treated as a separate substance. Same molecule, different delivery, different RCT base (Humbert 2003 et al.). Deserves its own entry — added to the future-link list below.
Intravenous high-dose vitamin C. Pharmacokinetically distinct from oral (Padayatty 2004), clinic-administered, not a consumer-actionable decision. Mentioned in misconceptions to disambiguate from Pauling-style oral megadose claims. Separate-entry candidate.
Sepsis/CITRIS-ALI critical-care protocols. Clinician territory; mentioned briefly in research dossier, not in article.

Hard rating calls.

mood = 0 after a draft at 1. The Carr & Maggini hospital-patient signal is real but conditional on baseline deficiency, and the article body doesn't carve out a mood-specific paragraph. Per meta §5a (score 0 freely; the article body must give a non-zero dimension a home), the honest call is 0 — fatigue improvement on repletion is captured under energy, not a separate mood track.
longevity = 2 was the hardest call. The observational signal (Khaw 2001, Aune 2018) is robust and large; the supplementation RCTs (PHS II, WACS) are null. The honest read is that adequate vitamin C status — however attained — sits in a cluster of behaviors that produce lower mortality, but the molecule alone via supplement does not bend the curve. Landed at 2 (small additive effect on mortality risk) rather than 3, because the molecule-specific causal contribution is uncertain.
health_short_term = 2 vs 3. Considered 3 for the periodontal/gum-bleeding effect in low-intake populations, but the average reader isn't low-intake and the felt change is modest. Held at 2.
evidence = 4 vs 5. Held at 4 because several headline RCT claims (CVD prevention, oncology megadose) failed despite mechanistic plausibility — a 5 should be reserved for entries where the headline claims survive.
controversy = 2. Considered 1 (universal consensus on RDA and mechanism) but the smoker-requirement gap (IOM +35 mg vs. Schectman ~+130 mg) and the observational-vs-RCT mortality split are active disputes among reasonable researchers.

Future-link candidates — entries that don't exist yet and should cross-link once they do:

topical-vitamin-c (cosmeceutical serums, separate substance)
iron-status or ferritin-testing (paired reading for the iron-absorption protocol)
iv-vitamin-c (oncology/critical-care)
fruit-and-vegetable-intake (the diet-pattern parent for which this entry is one component)

Audience scoping. Left global. The entry is genuinely a do-this-daily for most adults; the high-leverage subgroups (smokers, vegetarians, menstruating women, elderly, endurance athletes) are surfaced as audience-block bullets inside the audience section rather than narrowing the meta. Contraindications carry the actual exclusions (hemochromatosis, kidney disease).

Voice notes. The cold-prevention section is the highest-friction prose because the cultural prior ("vitamin C for colds") is strong and the data say otherwise. Tried to do the disambiguation honestly without sounding like a takedown — Cochrane finding on duration plus the endurance-subgroup carve-out preserve the truthful nuance.